Opportunity
New York State Contract Reporter #MS8991
SUNY Upstate Medical University Solicits Biologic Mesh and Tissue Implants (Strattice, Artia, AlloDerm, or Equivalent)
Posted
May 06, 2026
Respond By
May 28, 2026
Identifier
MS8991
NAICS
423450
SUNY Upstate Medical University is seeking vendors to supply a comprehensive range of biologic mesh and tissue implant products, or clinically equivalent alternatives, for use in medical and reconstructive surgical procedures. - Government Buyer: - State University of New York (SUNY) Upstate Medical University, Hospital Purchasing Department - OEMs and Vendors: - AbbVie/Allergan (notably Strattice, Artia, and AlloDerm brands) - Past contracts awarded to AbbVie/Allergan - Only vendors authorized by the original manufacturer may submit proposals - Products/Services Requested: - Extensive list of biological tissue implants, human tissue implants, and reconstructive matrices - Includes porcine and human tissue grafts, meshes, and matrices in various sizes and thicknesses - Brands and product lines: Strattice, Artia, AlloDerm Select, AlloDerm, Revolve - Surgical suction and adipose processing systems (e.g., Revolve, part number RV0001) - Each line item typically requested in a quantity of one - Detailed part numbers and descriptions provided for all items - Unique or Notable Requirements: - Vendors may propose equivalent or functionally equivalent products, but must provide clinical documentation and samples for evaluation - Compliance with New York State Finance Law §139 j&k (Lobbying Law) is required - Valid NYS Workman’s Compensation and Disability Forms must be submitted - Procurement is conducted under NYS authority to purchase from a consortium (GPO) when justified by price - Multi-year supply arrangement through June 2027 - Place of Performance/Delivery: - SUNY Upstate Medical University, Syracuse, NY
Description
SUNY Upstate Medical University intends to purchase medical products from a contract awarded by a consortium (GPO) pursuant to its authority under section 163 (3) (vi), which authorizes the purchase of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell products equivalent or functionally equivalent to those listed in the contract may contact the listed representative to discuss procurement. Equivalency must be demonstrated by meeting the clinical performance and KPIs of the products, and vendors must provide supporting clinical documentation and equipment for examination, demonstration, and trial. This procurement is subject to NYS Finance Law §139 j&k, also known as the Lobbying Law, and successful contractors must submit valid NYS Workman’s Compensation and Disability Forms.